Eisai Ltd
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- PARIET gastro-resistant tablet 10 mg
- PARIET gastro-resistant tablet 20 mg
- L01 - Antineoplásicos
- GLIADEL implant 7.7 mg
- HALAVEN solution for injection 0.44 mg/ml
- KISPLYX capsule, hard 10 mg
- KISPLYX capsule, hard 4 mg
- LENVIMA capsule, hard 10 mg
- LENVIMA capsule, hard 4 mg
- TARGRETIN capsule, soft 75 mg
- N03 - Antiepilépticos
- FYCOMPA film-coated tablet 10 mg
- FYCOMPA film-coated tablet 12 mg
- FYCOMPA film-coated tablet 2 mg
- FYCOMPA film-coated tablet 4 mg
- FYCOMPA film-coated tablet 6 mg
- FYCOMPA film-coated tablet 8 mg
- FYCOMPA oral suspension 0.5 mg/ml
- INOVELON film-coated tablet 100 mg
- INOVELON film-coated tablet 200 mg
- INOVELON film-coated tablet 400 mg
- INOVELON oral suspension 40 mg/ml
- ZEBINIX oral suspension 50 mg/ml
- ZEBINIX tablet 200 mg
- ZEBINIX tablet 800 mg
- ZONEGRAN capsule, hard 100 mg
- ZONEGRAN capsule, hard 25 mg
- ZONEGRAN capsule, hard 50 mg
- N06 - Psicoanalépticos
- ARICEPT EVESS orodispersible tablet 10 mg
- ARICEPT EVESS orodispersible tablet 5 mg
- ARICEPT film-coated tablet 10 mg
- ARICEPT film-coated tablet 5 mg